10371
|
ETCTN
|
A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10382
|
ETCTN
|
A Phase I/II Trial Evaluating the Safety and Efficacy of Eribulin in Combination with Copanlisib in Patients with Metastatic Triple Negative Breast Cancer
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10384
|
ETCTN
|
A Phase 1b/2 Study of Hu5F9-G4 (magrolimab) in Combination with Mogamulizumab in Relapsed/Refractory Treated T- cell Lymphoma
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10387
|
ETCTN
|
Pilot Trial of Nivolumab plus Cabozantinib for Advanced Solid Tumors in Patients with HIV infection
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10388
|
ETCTN
|
A Phase I Trial of Triapine and Lutetium Lu 177 Dotatate in Combination for Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10389
|
ETCTN
|
A Phase 1 Trial Combining WEE1 Inhibitor Adavosertib (AZD1775) with Radiation Therapy for Metastatic or Inoperable and Ineligible for Definitive Chemoradiation Esophageal and Gastroesophageal Junction Cancer
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10398
|
ETCTN
|
A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Chondrosarcoma and Clear Cell Sarcoma
|
Adult CIRB - Early Phase Emphasis
|
Completed
|
|
10399
|
ETCTN
|
A Phase 1 Study of Entinostat in Combination with Atezolizumab / Carboplatin / Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|
10401
|
ETCTN
|
A Phase 0 window-of-opportunity pharmacodynamic trial of triapine (NSC# 663249) in uterine corpus serous adenocarcinoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
10402
|
ETCTN
|
BAY 1895344 Plus Topoisomerase-1 (Top1) Inhibitors in Patients with Advanced Solid Tumors, Phase I Studies with Expansion Cohorts in Small Cell Lung Carcinoma (SCLC), Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) and Pancreatic Adenocarcinoma (PDA)
|
Adult CIRB - Early Phase Emphasis
|
Available to Open
|
|